(Q38142818)

29 August 2017

title

The utility of immunohistochemistry for providing genetic information on tumors (English)

1 reference

29 August 2017

1 reference

John K C Chan

1

1 reference

29 August 2017

Yiu-Tung Ip

series ordinal

2

1 reference

29 August 2017

Wah Cheuk

series ordinal

3

1 reference

29 August 2017

publication date

1 October 2013

1 reference

International Journal of Surgical Pathology

29 August 2017

published in

1 reference

29 August 2017

volume

21

1 reference

29 August 2017

issue

5

1 reference

29 August 2017

page(s)

455-475

1 reference

Sarcoma diagnosis in the age of molecular pathology

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft tissue and bone neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

A Distinctive Subset of PEComas Harbors TFE3 Gene Fusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Alveolar soft part sarcoma 'revisited': clinicopathological review of 47 cases from a tertiary cancer referral centre, including immunohistochemical expression of TFE3 in 22 cases and 21 other tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Technique for differentiating alveolar soft part sarcoma from other tumors in paraffin-embedded tissue: comparison of immunohistochemistry for TFE3 and CD147 and of reverse transcription polymerase chain reaction for ASPSCR1-TFE3 fusion transcript

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Cribriform-morular variant of papillary thyroid carcinoma--cytological and immunocytochemical findings of 18 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Hepatocellular adenoma: what is new in 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

p53 immunostaining as a significant adjunct diagnostic method for uterine surface carcinoma: precursor of uterine papillary serous carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

A Pathologist's Road Map to Benign, Precancerous, and Malignant Intraepithelial Proliferations in the Fallopian Tube

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

IDH1 and IDH2 mutations in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Diagnostic implications of IDH1-R132H and OLIG2 expression patterns in rare and challenging glioblastoma variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Monoclonal antibody specific for IDH1 R132H mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Application of mutant IDH1 antibody to differentiate diffuse glioma from nonneoplastic central nervous system lesions and therapy-induced changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Molecular distinction of chondrosarcoma from chondroblastic osteosarcoma through IDH1/2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Role of molecular studies in the diagnosis of lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

EGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Ascertaining an appropriate diagnostic algorithm using EGFR mutation-specific antibodies to detect EGFR status in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Immunostaining with EGFR mutation-specific antibodies: a reliable screening method for lung adenocarcinomas harboring EGFR mutation in biopsy and resection samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Mutation-specific antibodies for the detection of EGFR mutations in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Clinicopathological relevance of BRAF mutations in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

BRAF mutations in hairy-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Recurrent BRAF mutations in Langerhans cell histiocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

No evidence for BRAF-V600E mutations in gastroeosophageal tumors: results from a high-throughput analysis of 534 cases using a mutation-specific antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Detection of the BRAF V600E mutation in serous ovarian tumors: a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Utilization of a MAB for BRAF(V600E) detection in papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Immunohistochemical analysis of BRAF(V600E) expression of primary and metastatic melanoma and comparison with mutation status and melanocyte differentiation antigens of metastatic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II. The utility of microsatellite instability testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Immunohistochemical staining for DNA mismatch repair proteins in intestinal tract carcinoma: how reliable are biopsy samples?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Utility of immunohistochemistry in predicting microsatellite instability in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Clinical and biological significance of E-cadherin protein expression in invasive lobular carcinoma of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

INI1-deficient tumors: diagnostic features and molecular genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Intact INI1 gene region with paradoxical loss of protein expression in AT/RT: implications for a possible novel mechanism associated with absence of INI1 protein immunoreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Can MDM2 and CDK4 make the diagnosis of well differentiated/dedifferentiated liposarcoma? An immunohistochemical study on 129 soft tissue tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Epstein-Barr virus-associated lymphoproliferative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Epstein‐Barr virus in nasal T‐cell lymphomas (polymorphic reticulosis/midline malignant reticulosis) in Western China

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Expression of Epstein-Barr virus encoded latent genes in nasal T cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Diffuse large B-cell lymphoma associated with chronic inflammation as an incidental finding and new clinical scenarios

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

KSHV- and EBV-associated germinotropic lymphoproliferative disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Immunostaining for human herpesvirus 8 latent nuclear antigen-1 helps distinguish Kaposi sarcoma from its mimickers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Immunohistochemical detection of the human herpes virus 8 (HHV8) latent nuclear antigen-1 in Kaposi’s sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Immunohistochemical detection of human herpes virus-8 latent nuclear antigen-1 is useful in the diagnosis of Kaposi sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

p16 positive oropharyngeal squamous cell carcinoma:an entity with a favorable prognosis regardless of tumor HPV status

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Efficiency of immunohistochemical p16 expression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Immunohistochemical expression of p16(INK4a) is predictive of HR-HPV infection in cervical low-grade lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Increased p16 expression in high-grade serous and undifferentiated carcinoma compared with other morphologic types of ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

p16 Overexpression Identifies HPV-positive Vulvar Squamous Cell Carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

p16 expression in the female genital tract and its value in diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Partial p16 staining in oropharyngeal squamous cell carcinoma: extent and pattern correlate with human papillomavirus RNA status

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

p16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: a guide for interpretative relevance and consistency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

HPV analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Merkel cell polyomavirus: a newly discovered human virus with oncogenic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Merkel cell carcinoma with divergent differentiation: histopathological and immunohistochemical study of 15 cases with PCR analysis for Merkel cell polyomavirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Merkel cell polyomavirus expression in merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Merkel cell polyomavirus is frequently detected in korean patients with merkel cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Human Merkel cell polyomavirus: virological background and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

Merkel cell polyomavirus: a specific marker for Merkel cell carcinoma in histologically similar tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

The prevalence of Merkel cell polyomavirus in Japanese patients with Merkel cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896913502529

21 January 2018

Identifiers

DOI

10.1177/1066896913502529

1 reference

29 August 2017

1 reference